Site-Specific Keloid Fibroblasts Alter the Behaviour of Normal Skin and Normal Scar Fibroblasts through Paracrine Signalling

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Ashcroft, Kevin J ^a   Syed, Farhatullah ^a   Bayat, Ardeshir ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MOLECULAR MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KELOID; MALE; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN FIBROBLAST; UPREGULATION;

ADULT; AGED; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CICATRIX; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLASTS; HUMANS; KELOID; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 84892567601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075600     Document Type: Article

References (53)

1. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, et al. (2011) Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 164: 83-96.
2. Shih B, Garside E, McGrouther DA, Bayat A (2010) Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 18: 139-153.
3. Syed F, Bayat A (2012) Notch signaling pathway in keloid disease: Enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs. extralesional fibroblasts. Wound Repair and Regeneration 20: 688-706.
4. Syed F, Sherris D, Paus R, Varmeh S, Pandolfi PP, et al. (2012) Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor. A J Path 181:1642-1658.
5. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, et al. (1993) Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 55: 214-222.
6. Lee JY, Yang CC, Chao SC, Wong TW (2004) Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 26: 379-384.
7. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, et al. (1985) Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 84: 384-390.
8. Alaish SM, Yager DR, Diegelmann RF, Cohen IK (1995) Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 30: 949-952.
9. Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25: 26-32.
10. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F (1985) Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A 82: 5935-5939.
11. Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, et al. (2010) Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 130: 2489-2496.
12. Nirodi CS, Devalaraja R, Nanney LB, Arrindell S, Russell S, et al. (2000) Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen 8: 371-382.
13. Xue H, McCauley RL, Zhang W (2000) Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 89: 74-77.
14. Lim CP, Phan TT, Lim IJ, Cao X (2009) Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts. J Invest Dermatol 129: 851-861.
15. Lim IJ, Phan TT, Bay BH, Qi R, Huynh H, et al. (2002) Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol 283: C212-222.
16. Khoo YT, Ong CT, Mukhopadhyay A, Han HC, Do DV, et al. (2006) Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 208: 336-343.
17. Mukhopadhyay A, Tan EK, Khoo YT, Chan SY, Lim IJ, et al. (2005) Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices. Br J Dermatol 152: 639-645.
18. Peura M, Siltanen A, Saarinen I, Soots A, Bizik J, et al. (2010) Paracrine factors from fibroblast aggregates in a fibrin-matrix carrier enhance keratinocyte viability and migration. J Biomed Mater Res A 95: 658-664.
19. Koskela A, Engstrom K, Hakelius M, Nowinski D, Ivarsson M (2010) Regulation of fibroblast gene expression by keratinocytes in organotypic skin culture provides possible mechanisms for the antifibrotic effect of reepithelialization. Wound Repair Regen 18: 452-459.
20. Fujiwara M, Muragaki Y, Ooshima A (2005) Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 297: 161-169.
21. Hanasono MM, Kita M, Mikulec AA, Lonergan D, Koch RJ (2003) Autocrine growth factor production by fetal, keloid, and normal dermal fibroblasts. Arch Facial Plast Surg 5: 26-30.
22. Younai S, Nichter LS, Wellisz T, Reinisch J, Nimni ME, et al. (1994) Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 33: 148-151.
23. Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, et al. (2003) Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 120: 956-962.
24. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, et al. (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106: 729-733.
25. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, et al. (2008) Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 16: 254-265.
26. Shih B, McGrouther DA, Bayat A (2010) Identification of novel keloid biomarkers through profiling of tissue biopsies versus cell cultures in keloid margin specimens compared to adjacent normal skin. Eplasty 10: e24.
27. Bagabir RA, Syed F, Rautemaa R, McGrouther DA, Paus R, et al. (2011) Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in Keloid Scars. J Invest Dermatol 131: 2128-2130.
28. Bagabir R, Syed F, Paus R, Bayat A (2012) Longg-term organ culture of keloid disease tissue. Experimental dermatology 21: 376-381.
29. Xing JZ, Zhu L, Jackson JA, Gabos S, Sun XJ, et al. (2005) Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol 18: 154-161.
30. Syed F, Thomas AN, Singh S, Kolluru V, Hart SGE, et al. (2012) In vitro study of Novel Collagenase (Xiaflex®) on Dupuytren's disease fibroblasts displays unique drug related properties. PloS one 7: e31430.
31. Syed F, Sanganee HJ, Bahl A, Bayat A (2013) Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity. J Invest Dermatol 133: 1340-1350.
32. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV (2001) Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 107: 87-96.
33. Clark RA, McCoy GA, Folkvord JM, McPherson JM (1997) TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event. J Cell Physiol 170: 69-80.
34. Yu H, Bock O, Bayat A, Ferguson MW, Mrowietz U (2006) Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 59: 221-229.
35. Babu M, Diegelmann R, Oliver N (1992) Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 99: 650-655.
36. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, et al. (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 97: 240-248.
37. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 128: 1298-1310.
38. Satish L, Lyons-Weiler J, Hebda PA, Wells A (2006) Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen 14: 463-470.
39. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411.
40. Grotendorst GR (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179.
41. Babu M, Diegelmann R, Oliver N (1989) Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 9: 1642-1650.
42. Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim HS, et al. (2002) Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143: 1260-1269.
43. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, et al. (1999) Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 13: 1774-1786.
44. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, et al. (2000) Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 259: 213-224.
45. He S, Liu X, Yang Y, Huang W, Xu S, et al. (2010) Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol 162: 538-546.
46. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, et al. (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106: 1007-1011.
47. Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L (1999) Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype. Exp Cell Res 248: 634-642.
48. Tuan TL, Hwu P, Ho W, Yiu P, Chang R, et al. (2008) Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts. Am J Pathol 173: 1311-1325.
49. Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O (2007) Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 127: 98-105.
50. Lim CP, Phan TT, Lim IJ, Cao X (2006) Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. Oncogene 25: 5416-5425.
51. Park G, Yoon BS, Moon JH, Kim B, Jun EK, et al. (2008) Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol 128: 2429-2441.
52. Steffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, et al. (1998) Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 15: 199-213.
53. Pedroja BS, Kang LE, Imas AO, Carmeliet P, Bernstein AM (2009) Plasminogen activator inhibitor-1 regulates integrin avb3 expression and autocrine transforming growth factor b signaling. Journal of biological chemistry 284: 20708-20717.